滿貫集團(03390.HK)擬收購醫藥分銷商傑飛澳門一人剩餘股權
格隆匯4月1日丨滿貫集團(03390.HK)公佈,有關此前披露稱買方Key Zone Investment Inc.(公司的間接全資附屬公司)與賣方簡子傑先生訂立買賣協議,買方有條件同意購買目標公司傑飛澳門一人有限公司註冊股本80%,代價為3744萬港元。
於2022年4月1日,買方(公司的間接全資附屬公司)與賣方訂立買賣協議,據此,買方已購買,而賣方已出售購股權配額,代價為936萬港元。完成於緊隨簽署買賣協議後即吿發生。
目標公司主要於澳門從事藥品、中成藥及保健品的進口及分銷。購股權配額佔目標公司已發行股本的20%,而緊接完成前,目標公司由買方及賣方分別擁有80%及20%。完成後,目標公司將成為公司的全資附屬公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.